A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Adult Male Hypogonadism
Interventions
DRUG

Testosterone gel (FE 999303)

Trial Locations (22)

Unknown

Investigational site, Anniston

Investigational site, Huntsville

Investigational site, Newport Beach

Investigational site, Denver

Investigational site, New Haven

Investigational site, Aventura

Investigational site, Clearwater

Investigational site, Mishawaka

Investigational site, Watertown

Investigational site, Troy

Investigational site, Edison

Investigational site, Lawrence

Investigational site, Garden City

Investigational site, New York

Investigational site, Poughkeepsie

Investigational site, Purchase

Investigational site, Bala-Cynwyd

Investigational site, Warwick

Investigational site, Mt. Pleasant

Investigational site, Nashville

Investigational site, Webster

Investigational site, Norfolk

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02149264 - A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males | Biotech Hunter | Biotech Hunter